Marshall Wace’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-10,700
| Closed | -$411K | – | 2638 |
|
2023
Q2 | $411K | Buy |
+10,700
| New | +$411K | ﹤0.01% | 1643 |
|
2022
Q3 | – | Sell |
-265,351
| Closed | -$4.64M | – | 3457 |
|
2022
Q2 | $4.64M | Buy |
265,351
+201,617
| +316% | +$3.53M | 0.01% | 1236 |
|
2022
Q1 | $1.04M | Sell |
63,734
-123,293
| -66% | -$2.02M | ﹤0.01% | 1843 |
|
2021
Q4 | $3.05M | Buy |
+187,027
| New | +$3.05M | 0.01% | 1452 |
|
2019
Q4 | – | Sell |
-5,507
| Closed | -$29K | – | 2113 |
|
2019
Q3 | $29K | Buy |
+5,507
| New | +$29K | ﹤0.01% | 1530 |
|
2016
Q2 | – | Sell |
-22,332
| Closed | -$1.43M | – | 1207 |
|
2016
Q1 | $1.43M | Buy |
+22,332
| New | +$1.43M | 0.01% | 633 |
|